SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cell

Topics

Biology

Biochemistry

Medicine

Immunology

Pathology

Show all topics

DOI

10.1016/j.cell.2020.02.052

License

other-oa